{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:27:08Z","timestamp":1767857228053,"version":"3.49.0"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"DOI":"10.3389\/fpubh.2020.00261","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T11:28:33Z","timestamp":1594380513000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits"],"prefix":"10.3389","volume":"8","author":[{"given":"Andrew","family":"Stawasz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"B1","unstructured":"The Right Shot: Bringing Down Barriers to Affordable and Adapted Vaccines. 2nd ed.2015"},{"key":"B2","doi-asserted-by":"publisher","first-page":"eaaj2345","DOI":"10.1126\/scitranslmed.aaj2345","article-title":"The broad socioeconomic benefits of vaccination","volume":"10","author":"Bloom","year":"2018","journal-title":"Sci Trans Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.1016\/j.vaccine.2017.09.048","article-title":"Estimating the full public health value of vaccination","volume":"35","author":"Gessner","year":"2017","journal-title":"Vaccine."},{"key":"B4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.smim.2013.04.010","article-title":"Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil","volume":"25","author":"B\u00e4rnighausen","year":"2013","journal-title":"Semin Immunol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5005\/jp\/books\/12311_63","article-title":"New thinking on the value of vaccination\u2014globally and in India","volume-title":"Indian Academy of Pediatrics Textbook of Vaccines","author":"B\u00e4rnighausen","year":"2014"},{"key":"B6","doi-asserted-by":"publisher","first-page":"12313","DOI":"10.1073\/pnas.1400475111","article-title":"Valuing vaccination","volume":"111","author":"B\u00e4rnighausen","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"B52","DOI":"10.1016\/j.vaccine.2015.02.071","article-title":"Vaccines: from valuation to resource allocation","volume":"33","author":"Bloom","year":"2015","journal-title":"Vaccine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4324\/9780203791950-8","article-title":"The value of vaccination","volume":"6","author":"Bloom","year":"2005","journal-title":"World Econ."},{"key":"B9","first-page":"1","article-title":"The value of vaccination","volume-title":"Hot Topics in Infection Immunity in Children VII. Advances in Experimental Medicine and Biology, Vol 697","author":"Bloom","year":"2011"},{"key":"B10","first-page":"842","article-title":"Accounting for the full benefits of childhood vaccination in South Africa","volume":"98","author":"B\u00e4rnighausen","year":"2008","journal-title":"Med J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/j.vaccine.2010.11.090","article-title":"Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine","volume":"29","author":"B\u00e4rnighausen","year":"2011","journal-title":"Vaccine."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1080\/00036846.2011.566203","article-title":"The effect of vaccination on children's physical and cognitive development in the Philippines","volume":"44","author":"Bloom","year":"2011","journal-title":"Appl Econ."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/S2214-109X(13)70170-0","article-title":"Reassessing the value of vaccines","volume":"2","author":"B\u00e4rnighausen","year":"2014","journal-title":"Lancet Glob Health."},{"key":"B14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12889-015-1638-0","article-title":"Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study","volume":"15","author":"van der Putten","year":"2015","journal-title":"BMC Public Health."},{"key":"B15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1469-0691.2012.03977.x","article-title":"Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus","volume":"18","author":"B\u00e4rnighausen","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"B16","doi-asserted-by":"publisher","first-page":"A29","DOI":"10.1016\/j.vaccine.2016.12.001","article-title":"Moving beyond traditional valuation of vaccination: needs and opportunities","volume":"35","author":"Bloom","year":"2017","journal-title":"Vaccine."},{"key":"B17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12916-015-0446-9","article-title":"The broader economic impact of vaccination: reviewing and appraising the strength of evidence","volume":"13","author":"Jit","year":"2015","journal-title":"BMC Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.vaccine.2012.10.103","article-title":"Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review","volume":"31","author":"Ozawa","year":"2012","journal-title":"Vaccine."},{"key":"B19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2471\/BLT.16.178475","article-title":"Estimated economic impact of vaccinations in 73 low-and middle-income countries, 2001\u20132020","volume":"95","author":"Ozawa","year":"2017","journal-title":"Bull World Health Org."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0186903","DOI":"10.1371\/journal.pone.0186903","article-title":"The full benefits of adult pneumococcal vaccination: a systematic review","volume":"12","author":"Cafiero-Fonseca","year":"2017","journal-title":"PLoS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/21645515.2018.1451287","article-title":"Vaccination strategies for the prevention of meningococcal disease","volume":"14","author":"Vuocolo","year":"2018","journal-title":"Hum Vacc Immunother."},{"key":"B22","first-page":"E121","article-title":"Meningococcal disease in childhood: epidemiology, clinical features and prevention","volume":"56","author":"Bosis","year":"2015","journal-title":"J Prev Med Hygiene."},{"key":"B23","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jadohealth.2016.04.012","article-title":"The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines","volume":"59","author":"Pelton","year":"2016","journal-title":"J Adolescent Health."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.12688\/f1000research.11279.1","article-title":"Unraveling Neisseria meningitidis pathogenesis: from functional genomics to experimental models","volume":"6","author":"Soriani","year":"2017","journal-title":"F1000Res."},{"key":"B25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-319-28119-3_5","article-title":"Clinical aspects of meningococcal disease","volume-title":"Handbook of Meningococcal Disease Management.","author":"Pelton","year":"2016"},{"key":"B26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1478-7954-11-17","article-title":"Global epidemiology of invasive meningococcal disease","volume":"11","author":"Jafri","year":"2013","journal-title":"Popul Health Metrics."},{"key":"B27","article-title":"editor","volume-title":"Immunisation Against Infectious Disease (\u201cGreen Book\u201d).","author":"Ramsay","year":"2016"},{"key":"B28","unstructured":"Meningococcal Disease, Causes and Spread to Others2017"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2051013616681365","article-title":"Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States","volume":"5","author":"Banzhoff","year":"2017","journal-title":"Ther Adv Vacc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijid.2018.05.022","article-title":"Meningococcal carriage in high-risk settings: a systematic review","volume":"73","author":"Peterson","year":"2018","journal-title":"Int J Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/IPC.0000000000000197","article-title":"Addressing the challenges of serogroup B meningococcal disease outbreaks on campuses","volume":"22","author":"Schaffner","year":"2014","journal-title":"Infect Dis Clin Pract."},{"key":"B33","unstructured":"Meningococcal Serogroup B Cases and Outbreaks on US College Campuses2017"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3201\/eid1809.120257","article-title":"Trends in meningococcal disease in the United States military, 1971\u20132010","volume":"18","author":"Broderick","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1016\/j.vaccine.2018.06.030","article-title":"Prevention of meningococcal disease at mass gatherings: lessons from the hajj and umrah","volume":"36","author":"Yezli","year":"2018","journal-title":"Vaccine."},{"key":"B36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijid.2015.12.010","article-title":"Prevention of meningococcal disease during the hajj and umrah mass gatherings: past and current measures and future prospects","volume":"47","author":"Yezli","year":"2016","journal-title":"Int J Infect Dis."},{"key":"B37","volume-title":"Meningitis Outbreak Response in Sub-Saharan Africa","year":"2014"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2017.04.007","article-title":"Meningococcal disease in the middle east and Africa: findings and updates from the global meningococcal initiative","volume":"75","author":"Borrow","year":"2017","journal-title":"J Infect."},{"key":"B39","unstructured":"Invasive Meningococcal Disease \u2013 Serogroup Distribution, 20182018"},{"key":"B40","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4161\/hv.26816","article-title":"Routine vaccination against menB","volume":"10","author":"Kaaijk","year":"2014","journal-title":"Hum Vacc Immunother."},{"key":"B41","unstructured":"ABCs Report: Neisseria meningitidis, 2016Active Bacterial Core Surveillance (ABCs) Reports: Emerging Infections Program Network.2018"},{"key":"B42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.14745\/ccdr.v43i12a01","article-title":"HIV in Canada\u2013surveillance report, 2016","volume":"43","author":"Bourgeois","year":"2017","journal-title":"Can Commun Dis Rep."},{"key":"B43","unstructured":"Atlanta, GAHIV surveillance Report: Diagnoses of HIV Infection in the United States and Dependent Areas, 2016282017"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0177082","DOI":"10.1371\/journal.pone.0177082","article-title":"Short-term changes in the health state of children with group B meningococcal disease: a prospective, national cohort study","volume":"12","author":"Kennedy","year":"2017","journal-title":"PLoS ONE."},{"key":"B45","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.jadohealth.2016.03.041","article-title":"Deciphering the burden of meningococcal disease: conventional and under-recognized elements","volume":"59","author":"Martin\u00f3n-Torres","year":"2016","journal-title":"J Adolescent Health."},{"key":"B46","unstructured":"16227299Fact Sheet: Dengue and Severe Dengue.2018"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(13)60222-6","article-title":"Global burden of childhood pneumonia and diarrhoea","volume":"381","author":"Walker","year":"2013","journal-title":"Lancet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1001558","DOI":"10.1371\/journal.pmed.1001558","article-title":"Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study","volume":"10","author":"Simonsen","year":"2013","journal-title":"PLoS Med."},{"key":"B49","unstructured":"17007463Fact Sheet: Malaria.2018"},{"key":"B50","doi-asserted-by":"publisher","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: clinical presentation and sequelae","volume":"30","author":"Pace","year":"2012","journal-title":"Vaccine."},{"key":"B51","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","article-title":"Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study","volume":"11","author":"Viner","year":"2012","journal-title":"Lancet Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","article-title":"Clinical recognition of meningococcal disease in children and adolescents","volume":"367","author":"Thompson","year":"2006","journal-title":"Lancet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.vaccine.2015.11.057","article-title":"Clinical experience with the meningococcal B vaccine, Bexsero(\u00ae): prospects for reducing the burden of meningococcal serogroup B disease","volume":"34","author":"Watson","year":"2016","journal-title":"Vaccine."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/S1473-3099(15)00217-0","article-title":"Global incidence of serogroup B invasive meningococcal disease: a systematic review","volume":"15","author":"Sridhar","year":"2015","journal-title":"Lancet Infect Dis."},{"key":"B55","unstructured":"Serogroup B meningococcal (MenB) VISVaccine Information Statements2016"},{"key":"B56","unstructured":"Meningococcal Disease Vaccine.2018"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5365\/WPSAR.2013.4.4.001","article-title":"Invasive meningococcal disease in elderly people, New South Wales, Australia, 1993 to 2012","volume":"4","author":"Gunaratnam","year":"2013","journal-title":"Western Pac Surveill Response J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5694\/mja16.01340","article-title":"Epidemiology of invasive meningococcal B disease in Australia, 1999\u20132015: priority populations for vaccination","volume":"207","author":"Archer","year":"2017","journal-title":"Med J Aust."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1016\/j.ehrm.2011.08.001","article-title":"Costs of sequelae associated with invasive meningococcal disease: findings from a US managed care population","volume":"2","author":"Karve","year":"2011","journal-title":"Health Outcomes Res Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/hec.3259","article-title":"Measuring health spillovers for economic evaluation: a case study in meningitis","volume":"25","author":"Al-Janabi","year":"2016","journal-title":"Health Econ."},{"key":"B61","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40273-013-0057-2","article-title":"The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review","volume":"31","author":"Anonychuk","year":"2013","journal-title":"Pharmacoeconomics."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1016\/j.vaccine.2016.04.004","article-title":"Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero\u00ae to reduce meningococcal group B disease in Germany","volume":"34","author":"Christensen","year":"2016","journal-title":"Vaccine."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.4161\/hv.23888","article-title":"Cost-effectiveness of vaccination against meningococcal B among Dutch infants: crucial impact of changes in incidence","volume":"9","author":"Pouwels","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1016\/j.vaccine.2014.07.096","article-title":"Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada","volume":"32","author":"Tu","year":"2014","journal-title":"Vaccine."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.vaccine.2016.03.020","article-title":"Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France","volume":"34","author":"Lecocq","year":"2016","journal-title":"Vaccine."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(14)60226-9","article-title":"Group B meningococcal vaccine: recommendations for UK use","volume":"383","author":"Pollard","year":"2014","journal-title":"Lancet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e00566","DOI":"10.1128\/CVI.00566-16","article-title":"Recent progress in the prevention of serogroup B meningococcal disease","volume":"24","author":"Feavers","year":"2017","journal-title":"Clin Vaccin Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"D32","DOI":"10.1016\/j.vaccine.2015.05.101","article-title":"Vaccines for prevention of group B meningococcal disease: not your father's vaccines","volume":"33","author":"Harrison","year":"2015","journal-title":"Vaccine."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/XEB.0000000000000048","article-title":"Control of invasive meningococcal disease: is it achievable?","volume":"14","author":"Marshall","year":"2016","journal-title":"Int J Evidence Based Healthcare."},{"key":"B70","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(13)61572-X","article-title":"The price of prevention: what now for immunisation against meningococcus B?","volume":"382","author":"Moxon","year":"2013","journal-title":"Lancet."},{"key":"B71","first-page":"20","volume-title":"Infections invasives \u00e0 m\u00e9ningocoque (IIM)","year":"2018"},{"key":"B72","unstructured":"France\u2013Pharmaceuticals: Global Health Technology Assessment Road Map.2009"},{"key":"B73","unstructured":"30512637Vaccination Contre les Infections Invasives \u00c0 M\u00e9ningocoque B: Place du Vaccin Bexsero2013"},{"key":"B74","unstructured":"Germany: Recommended Vaccinations. 2017\/2018 Vaccine Scheduler.2017"},{"key":"B75","unstructured":"Standing Committee on Vaccination (STIKO).2016"},{"key":"B76","unstructured":"HoltorfAP\n            MatuszewskiK\n            NuijtenM\n            VauthC\n          Germany\u2013Pharmaceutical. International Society for Pharmacoeconomics and Outcomes Research.2009"},{"key":"B77","doi-asserted-by":"publisher","first-page":"509","DOI":"10.15585\/mmwr.mm6619a6","article-title":"Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine \u2013 advisory committee on immunization practices, 2016. Morbidity and Mortality Weekly Report (MMWR)","volume":"66","author":"Patton","year":"2017","journal-title":"Centers Dis Control Prev."},{"key":"B78","first-page":"22","volume-title":"Department of Health and Human Services, Advisory Committee on Immunization Practices (ACIP).","year":"2015"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.vaccine.2013.03.034","article-title":"Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact","volume":"31","author":"Christensen","year":"2013","journal-title":"Vaccine."},{"key":"B80","unstructured":"Public Health England. JCVI Position Statement on Use of Bexsero2014"},{"key":"B81","doi-asserted-by":"publisher","first-page":"g5725","DOI":"10.1136\/bmj.g5725","article-title":"Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study","volume":"349","author":"Christensen","year":"2014","journal-title":"BMJ."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet."},{"key":"B83","unstructured":"Meningitis B vaccination\n            BarberS\n          House of Commons Briefing Paper. No. 7569.2016"},{"key":"B84","unstructured":"KnaptonS\n          The TelegraphMeningitis B Vaccine Shortage Leaves Parents Unable to Get Jab Privately.2016"},{"key":"B85","unstructured":"Clinics to Receive Stocks of Meningitis B Vaccine After Global Shortage2016"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1080\/21645515.2016.1160177","article-title":"Vaccinating Italian infants with a new multicomponent vaccine (Bexsero\u00ae) against meningococcal B disease: a cost-effectiveness analysis","volume":"12","author":"Gasparini","year":"2016","journal-title":"Hum Vacc Immunother."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e1240","DOI":"10.1097\/MD.0000000000001240","article-title":"Enhanced estimates of the influenza vaccination effect in preventing mortality: a prospective cohort study","volume":"94","author":"Castilla","year":"2015","journal-title":"Medicine."},{"key":"B88","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S1473-3099(07)70236-0","article-title":"Mortality benefits of influenza vaccination in elderly people: an ongoing controversy","volume":"7","author":"Simonsen","year":"2007","journal-title":"Lancet Infect Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/vaccines7010005","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study","volume":"7","author":"Paynter","year":"2019","journal-title":"Vaccines."},{"key":"B90","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/0972-5229.148633","article-title":"Nosocomial infections in the intensive care unit: incidence, risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India","volume":"19","author":"Dasgupta","year":"2015","journal-title":"Indian J Crit Care Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/bmj.298.6673.568-a","article-title":"Nosocomial outbreak of group C meningococcal disease","volume":"298","author":"Eriksen","year":"1989","journal-title":"BMJ."},{"key":"B92","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/archinte.141.5.575","article-title":"Meningococcal pneumonia: a source of nosocomial infection","volume":"141","author":"Rose","year":"1981","journal-title":"Arch Intern Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1128\/JCM.00613-06","article-title":"Evidence for indirect nosocomial transmission of Neisseria meningitidis resulting in two cases of invasive meningococcal disease","volume":"44","author":"Elias","year":"2006","journal-title":"J Clin Microbiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e79880","DOI":"10.1371\/journal.pone.0079880","article-title":"The economic burden of meningitis to households in Kassena-Nankana district of Northern Ghana","volume":"8","author":"Akweongo","year":"2013","journal-title":"PLoS ONE."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1097\/PCC.0b013e3182192d7f","article-title":"Survivors of septic shock caused by Neisseria meningitidis in childhood: psychosocial outcomes in young adulthood","volume":"12","author":"Vermunt","year":"2011","journal-title":"Pediatr Crit Care Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/INF.0000000000001869","article-title":"Childhood infections and subsequent school achievement among 598,553 Danish children","volume":"37","author":"K\u00f6hler-Forsberg","year":"2018","journal-title":"Pediatr Infect Dis J."},{"key":"B97","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1080\/00036846.2015.1061647","article-title":"The effect of childhood measles vaccination on school enrolment in Matlab, Bangladesh","volume":"47","author":"Driessen","year":"2015","journal-title":"Appl Econ."},{"key":"B98","doi-asserted-by":"crossref","DOI":"10.7551\/mitpress\/9780262029179.001.0001","volume-title":"The Knowledge Capital of Nations: Education and the Economics of Growth.","author":"Hanushek","year":"2015"},{"key":"B99","doi-asserted-by":"publisher","first-page":"A787","DOI":"10.1016\/j.jval.2017.08.2302","article-title":"Calculating the indirect costs of adult pneumococcal disease and the rate of return to the 13-valent pneumococcal conjugate vaccine (PCV13) in older adults, with an application to Denmark","volume":"20","author":"Sevilla","year":"2017","journal-title":"Value Health."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/tmi.12370","article-title":"The economic burden of pneumonia and meningitis among children less than five years old in Hanoi, Vietnam","volume":"19","author":"Le","year":"2014","journal-title":"Trop Med Int Health."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1097\/INF.0b013e3182615297","article-title":"Costs of meningitis sequelae in children in Dakar, Senegal","volume":"31","author":"Griffiths","year":"2012","journal-title":"Pediatr Infect Dis J."},{"key":"B102","first-page":"1912","article-title":"The value of risks to life and health","volume":"31","author":"Viscusi","year":"1993","journal-title":"J Econ Lit."},{"key":"B103","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1471-2458-10-191","article-title":"Perception of epidemic's related anxiety in the general French population: a cross-sectional study in the Rh\u00f4ne-Alpes region","volume":"10","author":"Saadatian-Elahi","year":"2010","journal-title":"BMC Public Health."},{"key":"B104","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40273-015-0335-2","article-title":"Methods for health economic evaluation of vaccines and immunization decision frameworks: a consensus framework from a European vaccine economics community","volume":"34","author":"Ultsch","year":"2016","journal-title":"Pharmacoeconomics."},{"key":"B105","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1016\/j.vaccine.2007.04.070","article-title":"Do we fully understand the economic value of vaccines?","volume":"25","author":"Drummond","year":"2007","journal-title":"Vaccine."},{"key":"B106","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ."},{"key":"B108","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.vaccine.2016.11.071","article-title":"A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine","volume":"35","author":"Read","year":"2017","journal-title":"Vaccine."},{"key":"B110","unstructured":"South Australian Meningococcal B Vaccine Herd Immunity Study2020"},{"key":"B111","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/cid\/cir007","article-title":"\u2018Herd immunity\u2019: a rough guide","volume":"52","author":"Fine","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B112","doi-asserted-by":"publisher","first-page":"ofv117","DOI":"10.1093\/ofid\/ofv117","article-title":"Population-based surveillance of Neisseria meningitidis antimicrobial resistance in the United States","volume":"2","author":"Harcourt","year":"2015","journal-title":"Open Forum Infect Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1099\/jmm.0.000743","article-title":"Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016","volume":"67","author":"Gorla","year":"2018","journal-title":"J Med Microbiol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3201\/eid2308.170259","article-title":"Clonal expansion of new penicillin-resistant clade of Neisseria meningitidis serogroup W clonal complex 11, Australia","volume":"23","author":"Mowlaboccus","year":"2017","journal-title":"Emerg Infect Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/d41586-017-08323-0","article-title":"Deploy vaccines to fight superbugs","volume":"552","author":"Rappuoli","year":"2017","journal-title":"Nature."},{"key":"B116","doi-asserted-by":"publisher","first-page":"12911","DOI":"10.1073\/pnas.1717161115","article-title":"Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR","volume":"115","author":"Sevilla","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B117","doi-asserted-by":"publisher","first-page":"e00428","DOI":"10.1128\/mBio.00428-16","article-title":"How can vaccines contribute to solving the antimicrobial resistance problem?","volume":"7","author":"Lipsitch","year":"2016","journal-title":"mBio."},{"key":"B118","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.1016\/j.vaccine.2017.09.053","article-title":"Enhancing the role of vaccines in combatting antimicrobial resistance","volume":"35","author":"Clift","year":"2017","journal-title":"Vaccine."},{"key":"B119","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1016\/j.vaccine.2017.08.020","article-title":"Pneumococcal vaccination: direct and herd effect on carriage of vaccine types and antibiotic resistance in Icelandic children","volume":"35","author":"Sigurdsson","year":"2017","journal-title":"Vaccine."},{"key":"B120","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/jpids\/piw005","article-title":"The effect of 13-valent pneumococcal conjugate vaccine on the serotype distribution and antibiotic resistance profiles in children with invasive pneumococcal disease","volume":"6","author":"Gaviria-Agudelo","year":"2017","journal-title":"J Pediatr Infect Dis Soc."},{"key":"B121","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: a worldwide challenge","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet."},{"key":"B122","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(08)70281-0","article-title":"Impact of conjugate pneumococcal vaccines on antibiotic resistance","volume":"8","author":"Dagan","year":"2008","journal-title":"Lancet Infect Dis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4161\/hv.7.1.13692","article-title":"Cost of acute hospitalization and post-discharge follow-up care for meningococcal disease in the US","volume":"7","author":"Davis","year":"2011","journal-title":"Hum Vaccin."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1086\/644623","article-title":"Costs for households and community perception of meningitis epidemics in Burkina Faso","volume":"49","author":"Colombini","year":"2009","journal-title":"Clin Infect Dis."},{"key":"B125","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40272-012-0006-0","article-title":"Counting the cost of meningococcal disease: scenarios of severe meningitis and septicemia","volume":"15","author":"Wright","year":"2013","journal-title":"Pediatric Drugs."},{"key":"B126","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1016\/j.vaccine.2014.07.019","article-title":"Costs of surviving meningococcal disease in Spain: evaluation for two cases of severe meningitis and septicaemia","volume":"32","author":"Darb\u00e0","year":"2014","journal-title":"Vaccine."},{"key":"B127","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.healthpol.2014.02.009","article-title":"Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a QALY","volume":"116","author":"Nord","year":"2014","journal-title":"Health Policy."},{"key":"B128","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.socscimed.2015.10.005","article-title":"Attributes and weights in health care priority setting: a systematic review of what counts and to what extent","volume":"146","author":"Gu","year":"2015","journal-title":"Soc Sci Med."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e002929","DOI":"10.1136\/bmjopen-2013-002929","article-title":"The epidemiology of malpractice claims in primary care: a systematic review","volume":"3","author":"Wallace","year":"2013","journal-title":"BMJ Open."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.worlddev.2003.07.002","article-title":"The effect of health on economic growth: a production function approach","volume":"32","author":"Bloom","year":"2004","journal-title":"World Dev."},{"key":"B131","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.worlddev.2005.09.006","article-title":"The effect of population health on foreign direct investment inflows to low- and middle-income countries","volume":"34","author":"Alsan","year":"2006","journal-title":"World Dev."},{"key":"B132","unstructured":"Meningococcal Outbreaks.2017"},{"key":"B133","unstructured":"Serogroup B Meningococcal Disease Outbreaks on U.S. College Campuses.2019"},{"key":"B134","first-page":"787","article-title":"ACIP weighs in on meningococcal B vaccines","volume":"64","author":"Campos-Outcalt","year":"2015","journal-title":"J Fam Practice."},{"key":"B135","unstructured":"Managing an infectious disease outbreak in a schoolLessons Learned from School Crises Emergencies22007"},{"key":"B136","unstructured":"RoedelK\n          Lassen High School, Community College Shut Down Due to Viral Meningitis Cases2017"},{"key":"B137","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/cid\/ciy548","article-title":"Epidemiology of meningococcal disease outbreaks in the United States, 2009\u20132013","volume":"68","author":"Mbaeyi","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B138","doi-asserted-by":"publisher","first-page":"308","DOI":"10.7205\/MILMED-D-10-00283","article-title":"U.S. military fatalities due to Neisseria meningitidis: case reports and historical perspective","volume":"176","author":"Keiser","year":"2011","journal-title":"Military Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1728-4457.2001.00283.x","article-title":"Health interventions and health equity: the example of measles vaccination in Bangladesh","volume":"27","author":"Koenig","year":"2001","journal-title":"Popul Dev Rev."},{"key":"B140","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide","volume":"86","author":"Andre","year":"2008","journal-title":"Bull World Health Org."},{"key":"B141","unstructured":"925GenevaWHO PressGlobal Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks.2009"},{"key":"B142","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1377\/hlthaff.2017.0861","article-title":"The equity impact vaccines may have on averting deaths and medical impoverishment in developing countries","volume":"37","author":"Chang","year":"2018","journal-title":"Health Affairs."},{"key":"B143","doi-asserted-by":"publisher","first-page":"27043","DOI":"10.3402\/jmahp.v3.27043","article-title":"Role of vaccination in the sustainability of healthcare systems","volume":"3","author":"Largeron","year":"2015","journal-title":"J Market Access Health Policy."},{"key":"B144","article-title":"Initial Dose of a Multicomponent Serogroup B Meningococcal Vaccine in the Saguenay\u2013Lac-Saint-Jean Region. An Interimsafety Surveillance Report","author":"de Serres","year":"2014"},{"key":"B145","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study","volume":"383","author":"Daugla","year":"2014","journal-title":"Lancet."},{"key":"B146","unstructured":"Hajj and Umrah Health Requirements"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2020.00261\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T11:28:44Z","timestamp":1594380524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2020.00261\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":146,"alternative-id":["10.3389\/fpubh.2020.00261"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2020.00261","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"article-number":"261"}}